CORC

在结果中检索

CORC

浏览/检索结果: 共40条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Liu, Xin;  Fu, Meng;  Xia, Daqing;  Ji, Zimei;  Hu, Nana
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/22
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23
Progress on treatment of MET signaling pathway in non-small cell lung cancer 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020
作者:  Yu, Xiaoqing;  Yu, Sizhe;  Fan, Yun
收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01
A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer 期刊论文
CELL METABOLISM, 2019, 卷号: 30, 期号: 6, 页码: 1107-+
作者:  Huang, Ke;  Liang, Qian;  Zhou, Ye;  Jiang, Lu-lu;  Gu, Wei-ming
收藏  |  浏览/下载：77/0  |  提交时间：2020/07/01
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 3, 页码: 2977-2984
作者:  Wang, Hui-Li;  Liu, Yan-Chun;  Long, Ming-Peng;  Zheng, Chuan;  Yang, Jia-Hui
收藏  |  浏览/下载：95/0  |  提交时间：2019/11/07
Synthesis and Biological Evaluation of Oxopyrido[2,3-d] Pyrimidine-7-ones Derivatives as Covalent L85812/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors 期刊论文
LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 卷号: 16, 期号: 8, 页码: 826-834
作者:  Niu, Ao;  Wang, Yang;  Yang, Yushe;  Wei, Jianhai;  Ding, Jian
收藏  |  浏览/下载：12/0  |  提交时间：2020/07/01
Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology 期刊论文
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 卷号: 18, 页码: 17
作者:  Bing, Zhitong;  Cheng, Zhiyuan;  Shi, Danfeng;  Liu, Xinkui;  Tian, Jinhui
收藏  |  浏览/下载：90/0  |  提交时间：2019/10/09
Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology 期刊论文
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 卷号: 18
作者:  Bing, Zhitong;  Cheng, Zhiyuan;  Shi, Danfeng;  Liu, Xinkui;  Tian, Jinhui
收藏  |  浏览/下载：74/0  |  提交时间：2019/03/27
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy 期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 15, 页码: 3583-3592
作者:  Song, Jiangdian;  Shi, Jingyun;  Dong, Di;  Fang, Mengjie;  Zhong, Wenzhao
收藏  |  浏览/下载：63/0  |  提交时间：2018/10/10

©版权所有 ©2017 CSpace - Powered by CSpace